AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway
Chen Liu, Yuhan Huang, Tianyu Qin, Lixin You, Funian Lu, Dianxing Hu, Rourou Xiao, Qin Xu, Ensong Guo, Bin Yang, Xi Li, Junpeng Fan, Li Xiong, Yu Fu, Si Liu, Zhuozi Wang, Yingyu Dou, Wei Wang, Wenting Li, Xiaohang Yang, Jingbo Liu, Wenju Peng, Li Zhang, Yaoyuan Cui, Chaoyang Sun, Gang Chen
Topics & Concepts
PalbociclibProtein kinase BPI3K/AKT/mTOR pathwayCancer researchMAPK/ERK pathwayCell cycleMedicineCell cycle checkpointCancerPharmacologyApoptosisBreast cancerOncologyKinaseChemistryBiologyInternal medicineCell biologyBiochemistryMetastatic breast cancerAdvanced Breast Cancer TherapiesProtein Degradation and InhibitorsLung Cancer Research Studies